took aim at political rival

“These are debts that have a lot of impact and I think sometimes people don’t realize that if they missed (a payment), how bad it could be for them in other areas,” added Sotir.Here’s what you should know about credit card defaults.

There are several levels of consequences when credit card payments are not made. It begins with late fees, higher interest rates and a potentially lower credit score. If a borrower doesn’t pay for 30 days the bank considers the credit card “delinquent” and the borrower’s credit scores can be damaged further.When a borrower fails to make a payment for roughly six months, the bank considers the credit card in default, which means they will close your account and refer you to a collection agency, said Chip Lupo, writer at WalletHub.“That’s where you’re going to really have trouble obtaining future credit for a while,” said Lupo.

When a collection agency assumes your debt, they will reach out via phone, email and mail to encourage you to pay up. Eventually, if not paid, the collection agency may take legal action against the borrower.The first step is to be proactive, recommended Sotir. Whether it’s reaching out to your bank or working with a financial advisor, the quicker you start looking for viable solutions the more consequences you will be able to avoid.

“I’ve seen it over the years, when someone gets in trouble, it’s easy to cocoon and not want to deal with it,” said Sotir

Sotir and Bandebo recommend that you reach out to your credit card company to negotiate the debt since it’s in the bank’s best interest to help you catch up. If your account goes to a collections agency, find out if they can offer a payment plan or seek help from a non-profit credit counseling organization or financial advisor.to fight Covid-19 in record time.

Health Secretary Robert F. Kennedy Jr. has expressed deep skepticism regarding mRNA vaccines, despite real-world evidence that the vaccines are safe and saved millions of lives.The cancelation came as Moderna announced positive interim results from an early-stage trial of the vaccine that targeted H5 bird flu virus, tested in 300 healthy adults.

“While the termination of funding from HHS adds uncertainty, we are pleased by the robust immune response and safety profile observed in this interim analysis,” the company said in a statement.H5N1 bird flu viruses spilled from wild bird into cattle in the U.S. last year, infecting hundreds of animals in several states.